SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019231-21-000010
Filing Date
2021-09-24
Accepted
2021-09-23 18:56:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 taysha13ga.htm SC 13G 7971
  Complete submission text file 0001019231-21-000010.txt   9632
Mailing Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701
Business Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701 5122251630
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by) CIK: 0001019231 (see all company filings)

IRS No.: 742765082 | State of Incorp.: TX | Fiscal Year End: 0831
Type: SC 13G

Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Subject) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91724 | Film No.: 211273528
SIC: 2836 Biological Products, (No Diagnostic Substances)